| |
|
|
|
|
|
|
|||
|
D Ferrero, C Tarella, R Badoni, D Caracciolo, G Bellone, A Pileri and E Gallo
Dipartimento di Medicina, Universita di Torino, Italy.
Human recombinant GM-CSF (rGM-CSF) was tested on highly purified and
fractionated CFU-GM subsets. The fractionation was performed with the DS1-1
monoclonal antibody (MoAb), which distinguishes early and late CFU-GM. On
whole bone marrow cells, rGM-CSF had a colony-stimulating activity
comparable to that of known sources of CSFs, ie, the supernatant (SN) of
TPA 30-1 or 5637 cell lines, used as control. A greatly reduced activity
was observed when CFU-GM were depleted of phagocytizing and E rosetting
cells (colony growth of 27% as compared with control). On fractionated
CFU-GM, the rGM-CSF activity was even more reduced on both early and late
progenitors (18% and 6% of colony growth, respectively). However, when
rGM-CSF was used together with rG- CSF at suboptimal concentrations, the
colony growth reached values analogous to that of control cultures. A
synergistic interaction between rGM-CSF and rG-CSF in stimulating either
early or late myeloid progenitors was observed. The results suggest that
the activity of rGM- CSF on CFU-GM is mainly exerted through cooperation
with accessory cells. r-G-CSF is one of the factors that can
synergistically cooperate with r-GM-CSF in the myelopoietic stimulation.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1989 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||